Geode Capital Management, LLC Vista Gen Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.12 - $0.3 $21,262 - $53,156	177,189 Added 5.41%	3,449,805 $413,000
Q4 2022 Feb 13, 2023	SELL	$0.09 - $4.8 $9,636 - $513,960	-107,075 Reduced 3.17%	3,272,616 $337,000
Q3 2022 Nov 14, 2022	BUY	$0.14 - $4.8 $590 - $20,246	4,218 Added 0.12%	3,379,691 $514,000
Q2 2022 Aug 12, 2022	BUY	$0.88 - $1.73 $129,983 - $255,534	147,708 Added 4.58%	3,375,473 $2.97 Million
Q1 2022 May 13, 2022	BUY	$1.14 - $2.09 $176,818 - $324,167	155,104 Added 5.05%	3,227,765 $4 Million
Q4 2021 Feb 11, 2022	SELL	$1.67 - $2.76 $9,841 - $16,264	-5,893 Reduced 0.19%	3,072,661 $5.99 Million
Q3 2021 Nov 12, 2021	BUY	$2.62 - $3.45 $171,206 - $225,443	65,346 Added 2.17%	3,078,554 $8.44 Million
Q2 2021 Aug 13, 2021	BUY	$1.96 - $3.15 $3.87 Million - $6.23 Million	1,976,385 Added 190.62%	3,013,208 $9.49 Million
Q1 2021 May 12, 2021	BUY	$1.89 - $2.96 $1.42 Million - $2.22 Million	748,784 Added 259.96%	1,036,823 $2.21 Million
Q4 2020 Feb 12, 2021	BUY	$0.65 - $1.94 $23,648 - $70,583	36,383 Added 14.46%	288,039 $558,000
Q1 2020 May 14, 2020	BUY	$0.32 - $0.8 $660 - $1,650	2,063 Added 0.83%	251,656 $110,000
Q4 2019 Feb 13, 2020	BUY	$0.3 - $1.41 $24,222 - $113,844	80,741 Added 47.82%	249,593 $172,000
Q2 2019 Aug 14, 2019	BUY	$0.54 - $1.33 $7,773 - $19,145	14,395 Added 9.32%	168,852 $122,000
Q4 2018 Feb 13, 2019	BUY	$1.28 - $2.24 $22,682 - $39,695	17,721 Added 12.96%	154,457 $231,000
Q2 2018 Aug 14, 2018	BUY	$0.85 - $1.5 $90,643 - $159,958	106,639 Added 354.32%	136,736 $187,000
Q2 2017 Aug 14, 2017	BUY	N/A	30,097	30,097 $56,000

Others Institutions Holding VTGN

# of Institutions

Shares Held

27.1K

Call Options Held

Put Options Held

Personal Capital Advisors Corp

27.1K
Shares

$70,731
0.0% of portfolio

View Full List

About VistaGen Therapeutics, Inc.

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $540M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

More about VTGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account